KR
Km Rinki
About Km Rinki
Data last updated:
Km Rinki has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including J Zone Pharma Private Limited and Catex Pharama Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Catex Pharama Private Limited at ₹1.5 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Catex Pharama Private Limited U21001GJ2023PTC145074 | Director | 03 Oct 2023 | 2023 | ₹1.5 Lakh (FY 2024) | Active |
| J Zone Pharma Private Limited U24299UP2022PTC168168 | Director | 25 Jul 2022 | 2022 | – | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Km Rinki
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Km Rinki
Km Rinki has 4 years in corporate governance. Holds Director role. Currently with 2 companies, including J Zone Pharma Private Limited and Catex Pharama Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Catex Pharama Private Limited at ₹1.5 Lakh (FY 2024).
Km Rinki is associated with 2 companies as Director, including Catex Pharama Private Limited (₹1.5 Lakh), J Zone Pharma Private Limited.
Km Rinki has expertise in General Business.
Km Rinki has 4 years in corporate governance.
By reported revenue, the largest current company of Km Rinki is Catex Pharama Private Limited, with revenue of ₹1.5 Lakh (FY 2024).
Km Rinki currently holds positions at 2 companies: Catex Pharama Private Limited (₹1.5 Lakh), J Zone Pharma Private Limited.